http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2119484-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c902faf6ae746c51fc8010672fc22894 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D263-20 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-421 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-535 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D263-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D263-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-10 |
| filingDate | 1993-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1998-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2456bf4d5dc7348f7472c9278ba7985 |
| publicationDate | 1998-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2119484-C1 |
| titleOfInvention | Tropone-substituted phenyloxazolidinone or its pharmaceutically acceptable salts or hydrates |
| abstract | FIELD: chemistry of heterocyclic compounds. SUBSTANCE: products: tropone-substituted phenyloxazolidinones of the general formula (I) where R 1 is (C 1 -C 8 )--alkyl; R 2 and R 3 are similar or different and taken from hydrogen, fluorine or chlorine; R 4 is taken from group consisting of (a) , (b) or (c) ; R 5 is taken from group consisting of hydrogenm -OR 6 , -SR 6 , -NHR 7 , -NR 7 R 12 ,, (d) , (e) , (f) , (g) , (h) or (i) ; R 6 is H, (C 1 -C 8 )--alkyl possibly substituted with (C 1 -C 8 )--alkoxyles, (C 2 -C 8 )--alkenyl-(C 1 -C 8 )--alkyl or phenyl--(C 1 -C 8 )--alkyl; R 7 means -(C 1 -C 8 )--alkyl optionally substituted with hydroxy-group, phenyl or (C 1 -C 8 )--alkoxycarbonyl, (C 3 -C 8 )--cycloalkyl, (C 2 -C 8 )--alkynyl-(C 1 -C 10 )--alkyl, (C 2 -C 8 )-alkenyl-(C 1 -C 10 )--alkyl; R 8 is hydrogen, (C 1 -C 8 )-alkyl, (C 1 -C 8 )-acyl; R 9 and R 10 can be similar or different and mean H or (C 1 -C 8 )--alkyl; R 11 - H, hydroxy- or amino-group; R 12 is (C 1 -C 8 )-alkyl, or pharmaceutically acceptable salts or hydrates. Synthesized compounds of the formula (I) show antibacterial activity. EFFECT: improved method of synthesis. 19 cl, 3 tbl, 38 ex |
| priorityDate | 1992-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 251.